Agoracom: Small Cap Investment - Resverlogix Corp. - Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

Jul 25, 2021 02:32PM

Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

EggBeater66

Jul 25, 2021 03:29PM

Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

KOO-KOO2

Jul 25, 2021 03:30PM

sidebar

Rank: Treasurer [?]

Points: 608 [?]

Votes: 14 Score: 2.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

in response to

Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

KOO-KOO2

posted on Jul 27, 2021 12:42AM

twice a day pill from Pfizer. very interesting. 11 to 12 hours, wondering!

do you suppose Pfizer is the silent partner?

does it seem strange that Pfizer has developed a near similar drug to ABL or has it? thought we had a patent.

Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials